Pennsylvania COVID update: Weekly cases jump 30% to 13,936 as a monoclonal treatment proves ineffective against new variants and flu rates soar

COVID-19 infections jumped 30% in a week, with 70% of new cases caused by subvariants BQ.1 and BQ.1.1. Those variants are resistant to some monoclonal antibody treatments, causing the FDA to withdraw authorization for bebtelovimab, leaving the new boosters as the best hope for preventing severe illness. Meanwhile influenza case numbers are shattering records, with rates nearly doubling the highest recorded in the past 8 years.
Source: pennnews